Brandywine Global Investment Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Brandywine Global Investment Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,200	Closed	-$21K	–	969
2017 Q4	$21K	Buy	+4,200	New	+$20.4K	﹤0.01%	808
2015 Q2	–	Sell	-7,330	Closed	-$46K	–	1051
2015 Q1	$46K	Hold	7,330	–	–	﹤0.01%	862
2014 Q4	$42K	Hold	7,330	–	–	﹤0.01%	878
2014 Q3	$44K	Sell	7,330 -70	-0.9%	-$427	﹤0.01%	850
2014 Q2	$51K	Sell	7,400 -4,000	-35%	-$26.8K	﹤0.01%	840
2014 Q1	$83K	Sell	11,400 -200	-2%	-$1.38K	﹤0.01%	826
2013 Q4	$77K	Buy	+11,600	New	+$79K	﹤0.01%	836

Other funds holding JNP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Brandywine Global Investment Management's JNP Position: Q1 2018 in Review

Brandywine Global Investment Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q1 2018, closing a stake of 4,200 shares — an estimated $21K sold.

Brandywine Global Investment Management first reported a position in JNP in Q4 2013 and held it in 7 quarters. The position peaked at $83K in Q1 2014. 47 funds tracked by Wall St. Rank hold JNP as of Q1 2018.

Brandywine Global Investment Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Brandywine Global Investment Management sold 4,200 Juniper Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $21K.
Brandywine Global Investment Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2013 and held it in 7 quarters.
Brandywine Global Investment Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $83K in Q1 2014.
47 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Brandywine Global Investment Management's 13F filing for Q1 2018, filed 15 May 2018.